510(k) Report

510(k) · Cleared

Cleared

AFIAS iFOB with AFIAS-50

K163225510(k) TraditionalCleared Aug 8, 2017264-day reviewClass II21 CFR 864.6550

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Immunostics Inc., · OOX Automated Occult Blood Analyzer

Cleared on Aug 8, 2017 as substantially equivalent to K132167 (Boditech Med, Inc., 2014) after a 264-day review. Its family tree reaches back 2 generations to 2004.

Decided
Aug 8, 2017
Review
264 days
Class
Class II
Product code
OOX
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K041408 (2004). No later device cites it as a predicate yet.

  1. Root · 2 generations backK041408 Polymedco OC Auto Micro 80 Fob TestPolymedco, Inc. · 2004
  2. 1 generation backK132167 I-Chroma Ifob with I-Chroma ReaderBoditech Med, Inc. · 2014
  3. This deviceK163225 AFIAS iFOB with AFIAS-50Immunostics Inc., · 2017
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K041408Polymedco OC Auto Micro 80 Fob TestPolymedco, Inc.2004—
−1K132167I-Chroma Ifob with I-Chroma ReaderBoditech Med, Inc.2014—
0 (this device)K163225AFIAS iFOB with AFIAS-50Immunostics Inc.,2017—
FIG. 1 — Lineage of K163225, 2004–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OOX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OOX device

  1. #1 K200754 Hemosure Accu-Reader A100score 3.4 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K132167I-Chroma Ifob with I-Chroma Reader
Summary page 4
…i-CHROMA iFOB with i-CHROMA Reader Trade Name i-CHROMA iFOB Controls K Number K132167 1750 Brielle Ave. • A5 • Ocean, New Jersey • 07712…
Boditech Med, Inc.2014—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 13 years and passes through 3 companies; a new generation was cleared every 9.5 years on median.
  • None of the 2 ancestors has a recall.

How does its category compare?

All OOX devices

OOX Automated Occult Blood Analyzer: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · OOX

1in 2022

2010: 12014: 12017: 12020: 12022: 1
2007high 1 (2010) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OOX

Too few OOX 510(k)s in any year since 2007 to give a median.

Recalls per year · OOX

No recall names OOX since 2007.

Adverse event reports per year · OOX

No MAUDE report names OOX since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20101—00
20110—00
20120—00
20130—00
20141—00
20150—00
20160—00
20171—00
20180—00
20190—00
20201—00
20210—00
20221—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

AFIAS iFOB in conjunction with AFIAS 50 is a fluorescence immunoassay system for qualitative detection of fecal occult blood (FOB) in human fecal samples. AFIAS iFOB is an in vitro diagnostic test used by professional clinical laboratories and clinical reference laboratories for routine physical examination when gastrointestinal bleeding may be suspected. Intended users/operators for AFIAS iFOB is professional medical personnel.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K163225: AFIAS iFOB with AFIAS-50.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K163225

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026